Latest filing published 21 Oct 2026 for Bicara Therapeutics Inc., €400k.
Insider track record
David Raben: trading record in brief
This profile gathers the share dealings of David Raben in Bicara Therapeutics Inc. We count 3 filings; the first trade dates from 25 June 2026 and the latest from 21 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 21 October 2026, reports a transaction of €400k in Bicara Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Raben
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,777 shares@ US$18.1227CommonSEC144:0001950047-26-010350
- 50,000 shares@ US$28.56160.11% mcap51.8% of flowCommonSEC144:0001950047-26-006962
- 50,000 shares@ US$26.4930.070% mcap48.2% of flowCommonSEC144:0001950047-26-006490
3 of 3 declarations
